Secukinumab in Active Rheumatoid Arthritis after Anti-TNFα Therapy: A Randomized, Double-Blind Placebo-Controlled Phase 3 Study.
Hasan TahirAtul DeodharMark GenoveseTsutomu TakeuchiJacob AelionFilip Van den BoschSibylle HaemmerleHanno B RichardsPublished in: Rheumatology and therapy (2017)
ClinicalTrials.gov identifier: NCT01377012.